Frontlight ResearchEarly access
Type 2 diabetes trials in South Africa
6 of 7 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Benoni, Bloemfontein, Cape Town, Centurion, Century City, Durban, Gauteng, Johannesburg, Pietermaritzburg, Pretoria, Raslouw, Somerset West, Soweto, Tygervalley, Worcester, Wynberg
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - Phase 3Taking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Brackenfell, Cape Town, Claremont, Durban, eMkhomazi, Johannesburg, KwaDukuza, Paarl, Pretoria
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - Phase 3Taking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Bellville, Bloemfontein, Cape Town, Chatsworth, Claremont, Durban, eMkhomazi, Johannesburg, Midrand, Wentworth
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
- Where
- Bloemfontein, Cape Town, East London, eMkhomazi, Johannesburg, Kimberley, Krugersdorp, Lenasia, Paarl, Pretoria, Somerset West
- Age
- 18 years to 65 years
- People
- 130 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07613307 - Phase 3Active, not recruitingA Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Where
- Bloemfontein, Cape Town, Durban, Johannesburg, Lenasia, Mossel Bay, Paarl, Cape Town, Port Elizabeth, Pretoria, Somerset West
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00 - Phase 3Not yet taking people in South AfricaA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Where
- Brackenfell, Cape Town, Claremont, Durban, eMkhomazi, Johannesburg, KwaDukuza, Paarl, Pretoria
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00